FI110307B - Estrogeeni/progestiini/antiprogestiinia sisältävä ehkäisyvalmiste ja pakkaus - Google Patents
Estrogeeni/progestiini/antiprogestiinia sisältävä ehkäisyvalmiste ja pakkaus Download PDFInfo
- Publication number
- FI110307B FI110307B FI944022A FI944022A FI110307B FI 110307 B FI110307 B FI 110307B FI 944022 A FI944022 A FI 944022A FI 944022 A FI944022 A FI 944022A FI 110307 B FI110307 B FI 110307B
- Authority
- FI
- Finland
- Prior art keywords
- estrogen
- progestin
- antiprogestin
- day
- oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84305892A | 1992-03-02 | 1992-03-02 | |
US84305892 | 1992-03-02 | ||
US9301931 | 1993-03-02 | ||
PCT/US1993/001931 WO1993017686A1 (fr) | 1992-03-02 | 1993-03-02 | Procede par ×strogene/progesterone/antiprogesterone, kit pour contraception orale et regulation des regles |
CN93102182A CN1090481C (zh) | 1992-03-02 | 1993-03-02 | 雌激素/孕激素/抗孕激素的应用,其组合物和药盒 |
CN93102182 | 1993-03-02 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI944022A FI944022A (fi) | 1994-09-01 |
FI944022A0 FI944022A0 (fi) | 1994-09-01 |
FI110307B true FI110307B (fi) | 2002-12-31 |
Family
ID=25743002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI944022A FI110307B (fi) | 1992-03-02 | 1994-09-01 | Estrogeeni/progestiini/antiprogestiinia sisältävä ehkäisyvalmiste ja pakkaus |
Country Status (16)
Country | Link |
---|---|
US (1) | US7538099B1 (fr) |
EP (1) | EP0630246B1 (fr) |
JP (1) | JP4152431B2 (fr) |
CN (1) | CN1090481C (fr) |
AU (1) | AU678150B2 (fr) |
BR (1) | BR9306005A (fr) |
CZ (1) | CZ291988B6 (fr) |
FI (1) | FI110307B (fr) |
IL (1) | IL104915A (fr) |
MX (1) | MX9301121A (fr) |
NO (1) | NO311327B1 (fr) |
NZ (1) | NZ268304A (fr) |
PL (2) | PL172790B1 (fr) |
SK (1) | SK285963B6 (fr) |
WO (1) | WO1993017686A1 (fr) |
ZA (1) | ZA931492B (fr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9301121A (es) | 1992-03-02 | 1993-09-01 | Schering Ag | Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina. |
US5468736A (en) * | 1993-02-25 | 1995-11-21 | The Medical College Of Hampton Road | Hormone replacement therapy |
DE4335876A1 (de) * | 1993-10-17 | 1995-04-20 | Schering Ag | Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen |
US5521166A (en) * | 1994-12-19 | 1996-05-28 | Ortho Pharmaceitical Corporation | Antiprogestin cyclophasic hormonal regimen |
DE19531936A1 (de) * | 1995-08-17 | 1997-02-20 | Schering Ag | Kombinationspräparat zur Kontrazeption, Kits diese enthaltend und eine Methode diese verwendend |
US5898032A (en) | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
KR20010032056A (ko) | 1997-11-14 | 2001-04-16 | 에프.지.엠. 헤르만스 ; 이.에이치. 리링크 | 황체 호르몬-항 황체 호르몬 투약법 |
US6020328A (en) * | 1998-03-06 | 2000-02-01 | Research Triangle Institute | 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
US6262042B1 (en) | 1998-05-29 | 2001-07-17 | Research Triangle Institute | 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
US5962444A (en) * | 1998-05-29 | 1999-10-05 | Research Triangle Institute | 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
DE60014358D1 (de) * | 1999-04-29 | 2004-11-04 | Akzo Nobel Nv | Verwendung von org 33245 in der kombinierten intermittierenden hormontherapie und empfängnisverhütung |
CO5200773A1 (es) | 1999-08-31 | 2002-09-27 | Jenapharm Gmbh And Co Kg | Mesoprogestinas (moduladores de receptores para progestero- na) como componente de composiciones utilizadas para la terapia de sustitucion hormonal (trh) |
EP1453521B1 (fr) | 2001-12-05 | 2013-09-04 | Teva Women's Health, Inc. | Contraceptifs oraux pour eviter les grossesses et diminuer la symptomatologie premenstruelle |
US7772219B2 (en) | 2003-05-02 | 2010-08-10 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
AU2004257772B2 (en) | 2003-07-16 | 2009-12-17 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
TW200727920A (en) * | 2005-06-21 | 2007-08-01 | Organon Nv | New regimens for oral monophasic contraceptives |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9603856B2 (en) * | 2013-11-03 | 2017-03-28 | Flamina Holding Ag | Pharmaceutical composition or group of compositions for inhibiting autocrine HCG production in adult human cells |
RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
BR112016029338A2 (pt) | 2014-07-29 | 2017-08-22 | Therapeuticsmd Inc | creme transdérmico |
CA2966753A1 (fr) | 2014-11-17 | 2016-05-26 | Arno Therapeutics, Inc. | Compositions a liberation prolongee d'onapristone et methodes associees |
JP2018515552A (ja) * | 2015-05-18 | 2018-06-14 | アジル・セラピューティクス・インコーポレイテッドAgile Therapeutics, Inc. | 避妊用組成物ならびに有効性改善および副作用調節方法 |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017053793A1 (fr) | 2015-09-25 | 2017-03-30 | Arno Therapeutics, Inc. | Procédés de fabrication d'intermédiaires d'onapristone |
US10548905B2 (en) | 2015-12-15 | 2020-02-04 | Context Biopharma Inc. | Amorphous onapristone compositions and methods of making the same |
CA3020153A1 (fr) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Composition pharmaceutique d'hormone steroide |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
US20180148471A1 (en) | 2016-11-30 | 2018-05-31 | Arno Therapeutics, Inc. | Methods for onapristone synthesis dehydration and deprotection |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3890356A (en) | 1973-03-26 | 1975-06-17 | Richardson Merrell Inc | 7-Alkyl-{66 {hu 3,5{b -steroids |
US3928398A (en) | 1973-11-01 | 1975-12-23 | Richardson Merrell Inc | Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol |
US4018919A (en) * | 1975-07-16 | 1977-04-19 | Eli Lilly And Company | Sequential contraceptive method using two types of progestational agents |
US4416822A (en) | 1982-07-09 | 1983-11-22 | The Upjohn Company | 17β-Difluoromethyl steroids |
IL68222A (en) | 1983-03-24 | 1987-02-27 | Yeda Res & Dev | Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity |
US4780461A (en) | 1983-06-15 | 1988-10-25 | Schering Aktiengesellschaft | 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same |
ES8502612A1 (es) * | 1983-06-15 | 1985-02-01 | Schering Ag | Procedimiento para la preparacion de 13a-alquilgonanos |
AU572589B2 (en) | 1983-12-14 | 1988-05-12 | Upjohn Company, The | 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids |
IE61236B1 (en) * | 1986-07-15 | 1994-10-19 | American Home Prod | Combination dosage form for pre-menopausal women |
DE3702383A1 (de) | 1987-01-23 | 1988-08-04 | Schering Ag | 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate |
US5116818A (en) | 1987-03-10 | 1992-05-26 | Medical College Of Hampton Roads | Method and kit for contraception with GnRH-antagonist |
US5108995A (en) | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
MX9301121A (es) | 1992-03-02 | 1993-09-01 | Schering Ag | Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina. |
US5439913A (en) | 1992-05-12 | 1995-08-08 | Schering Aktiengesellschaft | Contraception method using competitive progesterone antagonists and novel compounds useful therein |
WO1993021926A1 (fr) | 1992-05-06 | 1993-11-11 | Medical College Of Hampton Roads | Reduction des hemorragies uterines secondaires liees a la prise de progesterone |
US5622943A (en) | 1992-05-06 | 1997-04-22 | The Medical College Of Hampton Roads | Minimizing progestin associated breakthrough bleeding |
US5516769A (en) | 1993-02-19 | 1996-05-14 | The Medical College Of Hampton Roads | Method of inhibiting fertilization |
US5468736A (en) | 1993-02-25 | 1995-11-21 | The Medical College Of Hampton Road | Hormone replacement therapy |
DE4344463A1 (de) | 1993-12-22 | 1995-06-29 | Schering Ag | Kombinationsprodukt zur Kontrazeption |
-
1993
- 1993-03-01 MX MX9301121A patent/MX9301121A/es active IP Right Grant
- 1993-03-02 JP JP51586993A patent/JP4152431B2/ja not_active Expired - Fee Related
- 1993-03-02 BR BR9306005A patent/BR9306005A/pt not_active Application Discontinuation
- 1993-03-02 EP EP93907185A patent/EP0630246B1/fr not_active Expired - Lifetime
- 1993-03-02 IL IL10491593A patent/IL104915A/en not_active IP Right Cessation
- 1993-03-02 ZA ZA931492A patent/ZA931492B/xx unknown
- 1993-03-02 AU AU37879/93A patent/AU678150B2/en not_active Ceased
- 1993-03-02 WO PCT/US1993/001931 patent/WO1993017686A1/fr active IP Right Grant
- 1993-03-02 CN CN93102182A patent/CN1090481C/zh not_active Expired - Fee Related
- 1993-03-02 NZ NZ268304A patent/NZ268304A/en not_active IP Right Cessation
- 1993-03-02 SK SK1046-94A patent/SK285963B6/sk unknown
- 1993-03-02 PL PL93316357A patent/PL172790B1/pl not_active IP Right Cessation
- 1993-03-02 PL PL93304807A patent/PL174785B1/pl not_active IP Right Cessation
-
1994
- 1994-09-01 NO NO19943234A patent/NO311327B1/no unknown
- 1994-09-01 FI FI944022A patent/FI110307B/fi active
- 1994-09-01 CZ CZ19942111A patent/CZ291988B6/cs not_active IP Right Cessation
-
1995
- 1995-06-05 US US08/462,703 patent/US7538099B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PL172790B1 (pl) | 1997-11-28 |
US7538099B1 (en) | 2009-05-26 |
ZA931492B (en) | 1993-12-23 |
AU3787993A (en) | 1993-10-05 |
PL174785B1 (pl) | 1998-09-30 |
EP0630246A1 (fr) | 1994-12-28 |
JP4152431B2 (ja) | 2008-09-17 |
CN1090481C (zh) | 2002-09-11 |
SK285963B6 (sk) | 2007-12-06 |
AU678150B2 (en) | 1997-05-22 |
JPH07509218A (ja) | 1995-10-12 |
NZ268304A (en) | 1997-02-24 |
IL104915A0 (en) | 1993-07-08 |
EP0630246B1 (fr) | 2008-07-16 |
IL104915A (en) | 1998-07-15 |
EP0630246A4 (fr) | 2002-07-17 |
SK104694A3 (en) | 1996-01-10 |
CZ291988B6 (cs) | 2003-07-16 |
NO943234D0 (no) | 1994-09-01 |
MX9301121A (es) | 1993-09-01 |
CZ211194A3 (en) | 1995-12-13 |
WO1993017686A1 (fr) | 1993-09-16 |
NO311327B1 (no) | 2001-11-19 |
NO943234L (no) | 1994-11-01 |
BR9306005A (pt) | 1998-06-23 |
CN1079386A (zh) | 1993-12-15 |
FI944022A (fi) | 1994-09-01 |
FI944022A0 (fi) | 1994-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI110307B (fi) | Estrogeeni/progestiini/antiprogestiinia sisältävä ehkäisyvalmiste ja pakkaus | |
DK174724B1 (da) | Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet | |
RU2169567C2 (ru) | Способ контрацепции женщин репродуктивного возраста, не достигших предменопаузы | |
US5108995A (en) | Hormone preparation and method | |
US5276022A (en) | Hormone preparation and method | |
AU630334B2 (en) | Hormone preparations for hormone replacement therapy and contraceptive method | |
US5256421A (en) | Hormone preparation and method | |
US7704983B1 (en) | Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception | |
JPH11508538A (ja) | ホルモン避妊用薬剤の複合調剤、キット及び避妊方法 | |
JPH11511157A (ja) | 避妊用複合調剤、複合調剤を含有するキット及び複合調剤の使用方法 | |
AU747710B2 (en) | Progestogen-antiprogestogen regimens | |
NZ230967A (en) | Oral contraceptive multiphase preparation; progestogenic and oestrogenic mixture in first phase progestogenic substance alone in second phase | |
RU2127112C1 (ru) | Эстроген (прогестин)антипрогестиновый способ пероральной контрацепции и регулирования менструации, фармацевтическая композиция и набор лекарственных средств | |
CA2134961C (fr) | Methode et trousses de contraceptifs oraux et de regulation des regles a base d'oestrogene, de progesterone et d'antiprogesterone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer of assignment of patent |
Owner name: EASTERN VIRGINIA MEDICAL SCHOOL Free format text: EASTERN VIRGINIA MEDICAL SCHOOL |